ATE217307T1 - Heterocyclisch substituierte propensäure derivate als nmda antagonisten - Google Patents
Heterocyclisch substituierte propensäure derivate als nmda antagonistenInfo
- Publication number
- ATE217307T1 ATE217307T1 AT95933902T AT95933902T ATE217307T1 AT E217307 T1 ATE217307 T1 AT E217307T1 AT 95933902 T AT95933902 T AT 95933902T AT 95933902 T AT95933902 T AT 95933902T AT E217307 T1 ATE217307 T1 AT E217307T1
- Authority
- AT
- Austria
- Prior art keywords
- acid derivatives
- propeneic
- nmda antagonists
- heterocyclic substituted
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08332016 US5563157B1 (en) | 1994-10-31 | 1994-10-31 | Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof |
| PCT/US1995/012085 WO1996013501A1 (en) | 1994-10-31 | 1995-09-21 | Heterocycle substituted propenoic acid derivatives as nmda antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE217307T1 true ATE217307T1 (de) | 2002-05-15 |
Family
ID=23296353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95933902T ATE217307T1 (de) | 1994-10-31 | 1995-09-21 | Heterocyclisch substituierte propensäure derivate als nmda antagonisten |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US5563157B1 (de) |
| EP (1) | EP0790994B1 (de) |
| JP (1) | JP3934678B2 (de) |
| KR (1) | KR100401138B1 (de) |
| CN (1) | CN1068001C (de) |
| AT (1) | ATE217307T1 (de) |
| AU (1) | AU696423B2 (de) |
| CA (1) | CA2202992C (de) |
| DE (1) | DE69526668T2 (de) |
| DK (1) | DK0790994T3 (de) |
| ES (1) | ES2173198T3 (de) |
| FI (1) | FI971831A7 (de) |
| HU (1) | HU222372B1 (de) |
| IL (1) | IL115791A (de) |
| MX (1) | MX9703146A (de) |
| NO (1) | NO313197B1 (de) |
| NZ (1) | NZ293842A (de) |
| PT (1) | PT790994E (de) |
| TW (1) | TW336232B (de) |
| WO (1) | WO1996013501A1 (de) |
| ZA (1) | ZA959046B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922752A (en) * | 1997-06-11 | 1999-07-13 | Hoechst Marion Roussell, Inc. | NMDA (n-methyl-d-aspartate) antagonists |
| GB9902455D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| AU2002211901A1 (en) | 2000-10-10 | 2002-04-22 | Smithkline Beecham Corporation | Substituted indoles, pharmaceutical compositions containing such indoles and their use as PPAR-gamma binding agents |
| US7375136B2 (en) * | 2001-03-08 | 2008-05-20 | Emory University | pH-dependent NMDA receptor antagonists |
| EA201070077A1 (ru) * | 2007-06-29 | 2010-08-30 | Эмори Юниверсити | Антагонисты nmda-рецепторов с нейропротективным действием |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0178469B1 (ko) * | 1990-07-16 | 1999-03-20 | 메이나드 알. 존슨 | 흥분성 아미노산 길항제 |
| DE69126438T2 (de) * | 1990-10-15 | 1997-10-02 | Astra Ab | 2-phenyl- und 2-thienyl-(2)-piperidinderivate mit neuroprotektiven eigenschaften |
| US5284862A (en) * | 1991-03-18 | 1994-02-08 | Warner-Lambert Company | Derivatives of 2-carboxyindoles having pharmaceutical activity |
| GB9208492D0 (en) * | 1992-04-16 | 1992-06-03 | Glaxo Spa | Heterocyclic compounds |
| JP3334805B2 (ja) * | 1993-05-27 | 2002-10-15 | メレルファーマスーティカルズ インコーポレイテッド | ３−（インドール−３−イル）−プロペン酸誘導体類及びその製剤組成物 |
| US5519048A (en) * | 1993-05-27 | 1996-05-21 | Merrell Pharmaceuticals Inc. | 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof |
-
1994
- 1994-10-31 US US08332016 patent/US5563157B1/en not_active Expired - Lifetime
-
1995
- 1995-09-21 JP JP51456396A patent/JP3934678B2/ja not_active Expired - Lifetime
- 1995-09-21 DK DK95933902T patent/DK0790994T3/da active
- 1995-09-21 FI FI971831A patent/FI971831A7/fi not_active IP Right Cessation
- 1995-09-21 DE DE69526668T patent/DE69526668T2/de not_active Expired - Lifetime
- 1995-09-21 CN CN95195799A patent/CN1068001C/zh not_active Expired - Fee Related
- 1995-09-21 ES ES95933902T patent/ES2173198T3/es not_active Expired - Lifetime
- 1995-09-21 KR KR1019970702840A patent/KR100401138B1/ko not_active Expired - Fee Related
- 1995-09-21 MX MX9703146A patent/MX9703146A/es unknown
- 1995-09-21 WO PCT/US1995/012085 patent/WO1996013501A1/en not_active Ceased
- 1995-09-21 AU AU36387/95A patent/AU696423B2/en not_active Ceased
- 1995-09-21 CA CA002202992A patent/CA2202992C/en not_active Expired - Lifetime
- 1995-09-21 AT AT95933902T patent/ATE217307T1/de not_active IP Right Cessation
- 1995-09-21 NZ NZ293842A patent/NZ293842A/en unknown
- 1995-09-21 EP EP95933902A patent/EP0790994B1/de not_active Expired - Lifetime
- 1995-09-21 PT PT95933902T patent/PT790994E/pt unknown
- 1995-09-21 HU HU9701941A patent/HU222372B1/hu not_active IP Right Cessation
- 1995-10-25 ZA ZA959046A patent/ZA959046B/xx unknown
- 1995-10-26 TW TW084111310A patent/TW336232B/zh active
- 1995-10-27 IL IL11579195A patent/IL115791A/xx not_active IP Right Cessation
-
1997
- 1997-04-29 NO NO19971991A patent/NO313197B1/no not_active IP Right Cessation
- 1997-12-15 US US08/990,673 patent/US5981553A/en not_active Expired - Lifetime
-
1999
- 1999-07-28 US US09/363,305 patent/US6180786B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IL115791A0 (en) | 1996-01-19 |
| NO313197B1 (no) | 2002-08-26 |
| MX9703146A (es) | 1997-06-28 |
| HU222372B1 (hu) | 2003-06-28 |
| EP0790994A1 (de) | 1997-08-27 |
| JPH10508019A (ja) | 1998-08-04 |
| NO971991D0 (no) | 1997-04-29 |
| DK0790994T3 (da) | 2002-08-26 |
| FI971831L (fi) | 1997-04-29 |
| US5981553A (en) | 1999-11-09 |
| AU696423B2 (en) | 1998-09-10 |
| AU3638795A (en) | 1996-05-23 |
| TW336232B (en) | 1998-07-11 |
| US5563157B1 (en) | 1999-02-02 |
| JP3934678B2 (ja) | 2007-06-20 |
| US5563157A (en) | 1996-10-08 |
| CN1161696A (zh) | 1997-10-08 |
| NZ293842A (en) | 1998-09-24 |
| US6180786B1 (en) | 2001-01-30 |
| IL115791A (en) | 2000-09-28 |
| FI971831A0 (fi) | 1997-04-29 |
| FI971831A7 (fi) | 1997-04-29 |
| NO971991L (no) | 1997-04-29 |
| DE69526668T2 (de) | 2003-01-02 |
| KR100401138B1 (ko) | 2003-12-24 |
| CN1068001C (zh) | 2001-07-04 |
| CA2202992A1 (en) | 1996-05-09 |
| ZA959046B (en) | 1996-05-17 |
| ES2173198T3 (es) | 2002-10-16 |
| HUT77174A (hu) | 1998-03-02 |
| WO1996013501A1 (en) | 1996-05-09 |
| EP0790994B1 (de) | 2002-05-08 |
| DE69526668D1 (de) | 2002-06-13 |
| PT790994E (pt) | 2002-08-30 |
| CA2202992C (en) | 2003-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200101177A1 (ru) | Производные индола в качестве антагонистов прогестерона | |
| DE69710319D1 (de) | Para-substituierte phenylpropansäure derivate als integrin-antagonisten | |
| EA200000920A1 (ru) | Производные бициклических гидроксамовых кислот | |
| FI980341A0 (fi) | 2-oksi-indolijohdannaisia | |
| DE69616480D1 (de) | Piperidinderivate als neurokininantagonisten | |
| DE69628804D1 (de) | Substitutierte heterozyclische Derivate als CRF Antagonisten | |
| EA200201179A1 (ru) | Производные 2-аминокарбонил-9h-пурина | |
| DE69706407D1 (de) | META-SUBSTITUIERTE PHENYLENDERIVATE UND IHRE VERWENDUNG ALS ALPHAvBETA3 INTERGRIN-ANTAGONISTEN ODER INHIBITOREN | |
| CH1175401H1 (de) | Piperazin Derivate verwendbar als CCR5 Antagonisten | |
| YU40997A (sh) | Novi oksadiazoli, postupci za njihovo pripremanje | |
| BG101110A (bg) | Заместени пиримидинови съединения и тяхното използване | |
| PT1007523E (pt) | Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao | |
| DE60100506D1 (de) | 1,3-dihydro-2h-indol-2-on derivate und deren verwendung als liganden der arginin-vasopressin rezeptoren v1b oder v1b und v1a | |
| BR9711586A (pt) | Compostos e uso dos mesmo | |
| DE69613457D1 (de) | 5-(4-subst.-piperidinyl-1)-3-aryl-pentansäure derivate als tachykinin rezeptor antagonisten | |
| ES2180573T3 (es) | Uso de derivados de indol como antagonistas de 5ht1. | |
| TR200200125T2 (tr) | Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar. | |
| CY1106376T1 (el) | Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν | |
| EA200100517A1 (ru) | Антагонисты 5ht1 для антидепрессантной терапии | |
| DE60131001D1 (de) | Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten | |
| NO963331L (no) | 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister | |
| ATE217307T1 (de) | Heterocyclisch substituierte propensäure derivate als nmda antagonisten | |
| BG103502A (en) | Heterocyclic derivatives of carboxylic acids, their preparation and application as endothelial receptor antagonists | |
| TR200001080T2 (tr) | 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri | |
| EA199700223A1 (ru) | Бициклические антагонисты тахикининов, их получение и применение в фармацевтической композиции |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |